A&M Managing Director Xuong Liu Featured in Nikkei Asia and Financial Times
In an interview by Nikkei Asia, Xuong Liu sheds light on concerns over China's slow recovery and geopolitical tensions as private equity investors are increasingly turning to India and Southeast Asia for investment opportunities. High interest rates and nervousness among backers about investing in China have contributed to this shift. India and Indonesia are emerging as popular destinations for these investors, with India surpassing China in healthcare buyout deals in the Asia-Pacific region.
However, entering these markets presents challenges, including a fragmented landscape, varying business practices, and limited exit options. Investors may face difficulties in conducting due diligence and sourcing deals in Southeast Asia, making it a complex transition. Despite potential long-term opportunities in China, caution currently prevails among investors. Read both articles below to gain understanding of the changing private equity climate in India and Southeast Asia.
Read the Nikkei Asia Article Read the FT Article
Canada’s Private Capital Outlook 2026: Infrastructure, Insight, and Operational Alpha
May 19, 2026
Canadian private capital enters 2026 in a state of disciplined optimism. The environment is more selective, more data-driven, and significantly more execution-focused than in prior cycles.
Infrastructure Pulse Survey Report: Spring 2026, North America and Europe
May 14, 2026
The Infrastructure Pulse Survey Report for Spring 2026, published by Alvarez & Marsal in collaboration with the Global Infrastructure Investor Association (GIIA), offers an insight into how investors across North America and Europe are reading the current investment landscape through a period of macroeconomic and geopolitical uncertainty.
Alvarez & Marsal Continues to Strengthen Transaction Advisory Practice in Australia with Senior Talent
May 13, 2026
Alvarez & Marsal (A&M), a leading global professional services firm, today announced the appointment of Sydney-based Roshan Emmanuel as a Managing Director within its Global Transaction Advisory Group (Global TAG), underscoring the firm’s rapid growth and continued investment in the Australian market.
Carving Out Success: Life Sciences Companies Are Rationalizing Portfolios by Divesting Non-Core Assets
May 12, 2026
Historically, large healthcare and life sciences corporations have focused deal activity on a breadth of diverse assets. However, the landscape is undergoing significant transformation as businesses shift to rationalize their portfolios and invest in fewer core areas.
